Requirements for COVID-19 clinical research
Researchers considering any COVID-19 clinical research, including studies that require Institutional Review Board (IRB) approval as well as quality improvement projects, are required to complete a short survey at COVID-19 Clinical Research Review.
The COVID-19 Clinical Research Review Panel — created by Ruth O’Hara, PhD, senior associate dean for research, and led by Kenneth Mahaffey, MD, vice chair of clinical research in the Department of Medicine, and Upinder Singh, MD, chief of infectious diseases in the Department of Medicine — will review the proposals and adjudicate for prioritization. The panel will also help foster collaboration and identify potential synergies across proposed clinical research studies and will evaluate efforts for ensuring research personnel and participant safety.
You may submit your protocol to IRB in parallel with the COVID-19 Clinical Research Review survey. However, the COVID-19 Clinical Research Review Panel will need to complete their review of your survey before IRB approval is granted. If you have any questions about the process, please contact Pooneh Fouladi at email@example.com.